Login / Signup

Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India.

Dharna GuptaNidhi GuptaNavneet SinghShankar Prinja
Published in: JCO global oncology (2024)
-positive NSCLC, respectively.
Keyphrases
  • small cell lung cancer
  • diffuse large b cell lymphoma
  • dna damage
  • cell death
  • advanced non small cell lung cancer
  • reactive oxygen species
  • protein kinase
  • oxidative stress